Complete title: T2012-002: A Pilot Study of Vincristine Sulfate Liposome Injection (Marqibo(R)) in Combination with UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults with Relapse of Acute Lymphoblastic Leukemia
| Research Study Number | T2012-002 |
| Principal Investigator | Todd Cooper |
| Phase | I |
Other eligibility criteria may apply.
| Research Study Number | T2012-002 |
| Contact | Todd Cooper |
| Telephone | 206/987-2106 |
Keywords: Leukemia, Acute Lymphoblastic (ALL); Hematologic Malignancies; Leukemia; Lymphoproliferative Disorders; Pediatric Cancers, Miscellaneous; Leukemia, Lymphoid; Immunoproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Immune System Diseases
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.